Boursier.com: Interview With Bart De Wever, Bonyf Scientific Director. Bonyf discreetly listed on the Paris Stock Exchange, Euronext Access, the Free Aftermarket, without raising money. What is the business of the company?
BBd W .: bonyf’s mission is to improve the lives and comfort of people suffering from oral diseases through innovative oral products. The long phase of R&D has resulted in the establishment of a wide range of patented products. Their marketing has started, but it’s still largely below what we can claim. Read More